Amanote Research
Register
Sign In
Synthesis and Evaluation of [18F]RAGER: A First Generation Small-Molecule PET Radioligand Targeting the Receptor for Advanced Glycation Endproducts
doi 10.1021/acschemneuro.5b00319.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Receptor for Advanced Glycation Endproducts (RAGE)
Science-Business eXchange
Evaluation of -1 Receptor Radioligand 18f-FTC-146 in Rats and Squirrel Monkeys Using PET
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Advanced Glycation Endproducts in Multiple Sclerosis
The Expression of the Receptor for Advanced Glycation Endproducts (RAGE) Is Permissive for Early Pancreatic Neoplasia
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Preclinical Evaluation and Non-Human Primate Receptor Occupancy Study of 18f-JNJ-64413739, a Novel PET Radioligand for P2X7 Receptors
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Imaging the Effect of Receptor for Advanced Glycation Endproducts on Angiogenic Response to Hindlimb Ischemia in Diabetes
EJNMMI Research
Nuclear Medicine
Radiology
Imaging
Receptor for Advanced Glycation Endproducts Mediates Pro-Atherogenic Responses to Periodontal Infection in Vascular Endothelial Cells
Atherosclerosis
Cardiovascular Medicine
Cardiology
Soluble Levels of Receptor for Advanced Glycation Endproducts (sRAGE) and Coronary Artery Disease: The Next C-Reactive Protein?
Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular Medicine
Cardiology
Receptor for Advanced Glycation Endproducts Controls Deleterious Lung Inflammation in Severe Pseudomonas Aeruginosa Pneumonia in Immunosuppressed Mice
Critical Care
Critical Care
Intensive Care Medicine
